587 related articles for article (PubMed ID: 15381645)
1. Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I.
Kaul P; Armstrong PW; Chang WC; Naylor CD; Granger CB; Lee KL; Peterson ED; Califf RM; Topol EJ; Mark DB
Circulation; 2004 Sep; 110(13):1754-60. PubMed ID: 15381645
[TBL] [Abstract][Full Text] [Related]
2. Impact of different patterns of invasive care on quality of life outcomes in patients with non-ST elevation acute coronary syndrome: results from the GUSTO-IIb Canada-United States substudy.
Kaul P; Armstrong PW; Fu Y; Knight JD; Clapp-Channing NE; Sutherland W; Granger CB; Mark DB;
Can J Cardiol; 2004 Jun; 20(8):760-6. PubMed ID: 15229756
[TBL] [Abstract][Full Text] [Related]
3. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.
Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD
CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819
[TBL] [Abstract][Full Text] [Related]
4. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States.
Mark DB; Naylor CD; Hlatky MA; Califf RM; Topol EJ; Granger CB; Knight JD; Nelson CL; Lee KL; Clapp-Channing NE
N Engl J Med; 1994 Oct; 331(17):1130-5. PubMed ID: 7935638
[TBL] [Abstract][Full Text] [Related]
5. Higher rates of coronary angiography and revascularization following myocardial infarction may be associated with greater survival in the United States than in Canada. The CARS Investigators (Coumadin/Aspirin Reinfarction Study).
Langer A; Fisher M; Califf RM; Goodman S; O'Connor CM; Harrington RA; Fuster V
Can J Cardiol; 1999 Oct; 15(10):1095-102. PubMed ID: 10523476
[TBL] [Abstract][Full Text] [Related]
6. Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
Barbash GI; White HD; Modan M; Diaz R; Hampton JR; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso EA; Van der Werf T
Arch Intern Med; 1994 Oct; 154(19):2237-42. PubMed ID: 7944845
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial.
Singh M; White J; Hasdai D; Hodgson PK; Berger PB; Topol EJ; Califf RM; Holmes DR
J Am Coll Cardiol; 2007 Oct; 50(18):1752-8. PubMed ID: 17964038
[TBL] [Abstract][Full Text] [Related]
9. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
Tricoci P; Lokhnygina Y; Berdan LG; Steinhubl SR; Gulba DC; White HD; Kleiman NS; Aylward PE; Langer A; Califf RM; Ferguson JJ; Antman EM; Newby LK; Harrington RA; Goodman SG; Mahaffey KW
Circulation; 2007 Dec; 116(23):2669-77. PubMed ID: 18025532
[TBL] [Abstract][Full Text] [Related]
10. Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigators.
Chang WC; Fu Y; Ohman EM; Gupta M; Morris A; Roth SN; Granger CB; Califf RM; Topol EJ; Mark DB; Armstrong PW
Can J Cardiol; 2000 Oct; 16(10):1231-9. PubMed ID: 11064297
[TBL] [Abstract][Full Text] [Related]
11. Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials.
Hasdai D; Topol EJ; Kilaru R; Battler A; Harrington RA; Vahanian A; Ohman EM; Granger CB; Van de Werf F; Simoons ML; O'connor CM; Holmes DR
Am Heart J; 2003 Jan; 145(1):73-9. PubMed ID: 12514657
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
Mark DB; Hlatky MA; Califf RM; Naylor CD; Lee KL; Armstrong PW; Barbash G; White H; Simoons ML; Nelson CL
N Engl J Med; 1995 May; 332(21):1418-24. PubMed ID: 7723799
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of precordial ST segment depression on admission electrocardiogram in patients with inferior wall myocardial infarction.
Birnbaum Y; Herz I; Sclarovsky S; Zlotikamien B; Chetrit A; Olmer L; Barbash GI
J Am Coll Cardiol; 1996 Aug; 28(2):313-8. PubMed ID: 8800103
[TBL] [Abstract][Full Text] [Related]
14. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Van de Werf F; Topol EJ; Lee KL; Woodlief LH; Granger CB; Armstrong PW; Barbash GI; Hampton JR; Guerci A; Simes RJ
JAMA; 1995 May 24-31; 273(20):1586-91. PubMed ID: 7745771
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: insights from GUSTO I Economics and Quality of Life substudy.
Barbagelata A; Califf RM; Sgarbossa EB; Knight D; Mark DB; Granger CB; Armstrong PW; Elizari M; Birnbaum Y; Grinfeld LR; Ohman EM; Wagner GS;
Am Heart J; 2004 Nov; 148(5):795-802. PubMed ID: 15523309
[TBL] [Abstract][Full Text] [Related]
16. Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. GUSTO Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Tardiff BE; Califf RM; Morris D; Bates E; Woodlief LH; Lee KL; Green C; Rutsch W; Betriu A; Aylward PE; Topol EJ
J Am Coll Cardiol; 1997 Feb; 29(2):240-9. PubMed ID: 9014973
[TBL] [Abstract][Full Text] [Related]
17. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators.
Every NR; Parsons LS; Hlatky M; Martin JS; Weaver WD
N Engl J Med; 1996 Oct; 335(17):1253-60. PubMed ID: 8857004
[TBL] [Abstract][Full Text] [Related]
18. Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial.
Simes RJ; O'Connell RL; Aylward PE; Varshavsky S; Diaz R; Wilcox RG; Armstrong PW; Granger CB; French JK; Van de Werf F; Marschner IC; Califf R; White HD;
Am Heart J; 2010 Jun; 159(6):988-97. PubMed ID: 20569711
[TBL] [Abstract][Full Text] [Related]
19. Thrombolysis followed by early revascularization: an effective reperfusion strategy in real world patients with ST-elevation myocardial infarction.
Jaffe R; Halon DA; Karkabi B; Goldstein J; Rubinshtein R; Flugelman MY; Lewis BS
Cardiology; 2007; 107(4):329-36. PubMed ID: 17268198
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of precordial ST segment depression during inferior myocardial infarction in the thrombolytic era: results in 16,521 patients.
Peterson ED; Hathaway WR; Zabel KM; Pieper KS; Granger CB; Wagner GS; Topol EJ; Bates ER; Simoons ML; Califf RM
J Am Coll Cardiol; 1996 Aug; 28(2):305-12. PubMed ID: 8800102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
